Start a logbook of all your symptoms, food, drink and medications and exercise
In the peptide therapy context, AbbVie's Lupron (leuprolide) franchise treating prostate cancer, endometriosis, uterine fibroids, and precocious puberty via GnRH agonism remains a stable legacy contributor, while Botox Therapeutic ($748 million in Q1 2024 alone) constitutes a significant peptide-adjacent revenue stream
Daily subcutaneous injection is the standard protocol in supervised clinical settings, typically dosed once daily or split into twice daily depending on the indication and the providers assessment
Research by a Croatian team (which pioneered BPC-157 studies) has shown it can safeguard various organs from damage
GHK-Cu + BPC-157 (healing and regeneration) Why combine: GHK-Cu: Tissue regeneration, collagen BPC-157: Healing, inflammation reduction Complementary mechanisms Powerful healing stack Protocol: GHK-Cu: 1-2mg, 3-5x weekly BPC-157: 250-500mcg, twice daily Both injectable Can inject separately or mix Benefits: Maximum wound healing Comprehensive tissue repair Reduced inflammation Better overall recovery See BPC-157 guide , BPC-157 benefits , how to take BPC-157 , is BPC-157 banned , BPC-157 5mg dosing guide , BPC-157 dosage calculator , BPC-157 vs TB-500 , BPC-157 alternatives , and peptides for gut health
2 3 8 Made for your biology No two people age the same way, so no two treatments are exactly the same